Swiss National Bank Cara Therapeutics, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$4.89 - $12.27 $56,723 - $142,332	-11,600 Reduced 10.53%	98,600 $484,000
Q4 2022 Feb 08, 2023	BUY	$8.88 - $12.77 $19,536 - $28,094	2,200 Added 2.04%	110,200 $1.18 Million
Q3 2022 Nov 09, 2022	BUY	$8.24 - $12.56 $15,656 - $23,864	1,900 Added 1.79%	108,000 $1.01 Million
Q2 2022 Aug 09, 2022	BUY	$7.45 - $13.84 $37,250 - $69,200	5,000 Added 4.95%	106,100 $969,000
Q1 2022 May 09, 2022	BUY	$9.94 - $12.65 $130,214 - $165,715	13,100 Added 14.89%	101,100 $1.23 Million
Q2 2021 Aug 06, 2021	SELL	$12.38 - $29.19 $250,076 - $589,638	-20,200 Reduced 18.67%	88,000 $1.26 Million
Q1 2021 May 07, 2021	BUY	$15.07 - $21.71 $111,518 - $160,654	7,400 Added 7.34%	108,200 $2.35 Million
Q3 2020 Nov 09, 2020	BUY	$12.34 - $17.92 $22,212 - $32,256	1,800 Added 1.82%	100,800 $1.28 Million
Q2 2020 Aug 05, 2020	BUY	$12.39 - $17.33 $216,825 - $303,274	17,500 Added 21.47%	99,000 $1.69 Million
Q1 2020 May 08, 2020	BUY	$9.12 - $17.78 $11,855 - $23,114	1,300 Added 1.62%	81,500 $1.08 Million
Q4 2019 Feb 06, 2020	BUY	$16.11 - $25.98 $59,607 - $96,126	3,700 Added 4.84%	80,200 $1.29 Million
Q3 2019 Nov 12, 2019	BUY	$18.28 - $26.91 $191,940 - $282,555	10,500 Added 15.91%	76,500 $1.4 Million
Q2 2019 Aug 02, 2019	BUY	$17.68 - $21.57 $86,632 - $105,693	4,900 Added 8.02%	66,000 $1.42 Million
Q1 2019 May 10, 2019	BUY	$14.41 - $19.64 $28,820 - $39,280	2,000 Added 3.38%	61,100 $1.2 Million
Q4 2018 Feb 13, 2019	BUY	$12.45 - $23.47 $37,350 - $70,410	3,000 Added 5.35%	59,100 $768,000
Q3 2018 Nov 08, 2018	BUY	$17.57 - $23.95 $147,588 - $201,180	8,400 Added 17.61%	56,100 $1.34 Million
Q1 2018 May 04, 2018	BUY	$11.77 - $16.08 $63,558 - $86,831	5,400 Added 12.77%	47,700 $591,000
Q3 2017 Nov 03, 2017	BUY	$12.6 - $16.34 $532,980 - $691,182	42,300	42,300 $579,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$11 Million
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$8.31 Million
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$7.59 Million
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$5.43 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$5.41 Million
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account